Close

Noble Financial Assumes Heron Therapeutics (HRTX) at Buy Oct 5, 2017 12:07PM
Noble Financial Affirms Heron Therapeutics (HRTX) at 'Buy'; Says Delay in Sustol Approval was Unusual Apr 19, 2016 12:43PM
Noble Affirms Heron Therapeutics (HRTX) at 'Buy' Ahead of FDA Decision on Sustol; Pipeline Progress Highlighted Feb 22, 2016 11:33AM
Noble Financial Comments on Heron Therapeutics' (HRTX) Pipeline Ahead of Sustol PDUFA Jan 6, 2016 08:50AM
Noble Financial Boosts PT on Heron Therapeutics (HRTX) to $41 Following SUSTOL NDA Resubmission Jul 22, 2015 09:32AM


Mar 20, 2015 10:52AM Heron Therapeutics' (HRTX) HTX-011 Phase 1 Meets PK Goals; Noble Financial Maintains 'Buy' Rating
Jun 25, 2014 09:25AM Heron Therapeutics (HRTX) Prices 4.5M Offering at $11.75/sh